Crossmark

Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial

Crossref DOI link: https://doi.org/10.1007/s00432-025-06190-1

Published Online: 2025-04-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Surov, Alexey

Thormann, Maximilian

Wienke, Andreas

Ricke, Jens

Seidensticker, Max
Funding

Funding for this research was provided by:

Charité - Universitätsmedizin Berlin
License Information

Text and Data Mining valid from 2025-04-16

Version of Record valid from 2025-04-16
More Information

Article History

Received: 5 March 2025

Accepted: 31 March 2025

First Online: 16 April 2025

Declarations

:

: The authors declare no competing interests.

: Institutional Review Board approval was obtained.

: Written informed consent was waived by the Institutional Review Board

: The scientific guarantor of this study is Alexey Surov.

: One author has significant statistical expertise (Andreas Wienke).

: No study subjects or cohorts have been previously reported.

Document is current

Any future updates will be listed below